{
  "pmid": "22547173",
  "uid": "22547173",
  "title": "Direct thrombin inhibitors in cardiovascular disease.",
  "abstract": "Limitations of commonly used anticoagulants, unfractionated heparin, low-molecular-weight heparin, and oral vitamin K antagonists have prompted the development of alternative therapies. Direct thrombin inhibitors are a new class of anticoagulants that bind directly to thrombin and inhibit its interaction with substrates. In this Review, we critically examine the evidence from randomized controlled trials for the efficacy and safety of the parenteral direct thrombin inhibitors bivalirudin and argatroban, and the novel oral direct thrombin inhibitor dabigatran etexilate, in cardiovascular and thrombotic disease.",
  "authors": [
    {
      "last_name": "Arsenault",
      "fore_name": "Kyle A",
      "initials": "KA",
      "name": "Kyle A Arsenault",
      "affiliations": [
        "Michael G. DeGroote School of Medicine, McMaster University, 1280 Main Street West, Hamilton, ON L8S 4L8, Canada. arsenault.ka@gmail.com"
      ]
    },
    {
      "last_name": "Hirsh",
      "fore_name": "Jack",
      "initials": "J",
      "name": "Jack Hirsh",
      "affiliations": []
    },
    {
      "last_name": "Whitlock",
      "fore_name": "Richard P",
      "initials": "RP",
      "name": "Richard P Whitlock",
      "affiliations": []
    },
    {
      "last_name": "Eikelboom",
      "fore_name": "John W",
      "initials": "JW",
      "name": "John W Eikelboom",
      "affiliations": []
    }
  ],
  "journal": {
    "title": "Nature reviews. Cardiology",
    "iso_abbreviation": "Nat Rev Cardiol",
    "issn": "1759-5010",
    "issn_type": "Electronic",
    "volume": "9",
    "issue": "7",
    "pub_year": "2012",
    "pub_month": "May",
    "pub_day": "01"
  },
  "start_page": "402",
  "end_page": "414",
  "pages": "402-14",
  "language": "eng",
  "publication_types": [
    "Journal Article",
    "Review"
  ],
  "keywords": [
    "Administration, Oral",
    "Animals",
    "Antithrombins",
    "Blood Coagulation",
    "Cardiovascular Diseases",
    "Evidence-Based Medicine",
    "Hemorrhage",
    "Humans",
    "Infusions, Parenteral",
    "Risk Assessment",
    "Risk Factors",
    "Treatment Outcome"
  ],
  "article_ids": {
    "pubmed": "22547173",
    "doi": "10.1038/nrcardio.2012.61",
    "pii": "nrcardio.2012.61"
  },
  "doi": "10.1038/nrcardio.2012.61",
  "dates": {
    "completed": "2012-10-29",
    "revised": "2021-10-21"
  },
  "chemicals": [
    "Antithrombins"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "current_affiliation",
    "retrieved_date": "2025-07-30T15:09:13.079513",
    "pmid": "22547173"
  }
}